• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

cardiovalve

Court sides with Cardiovalve in Edwards patent spat

June 10, 2025 By Sean Whooley

The U.S. Court of Appeals for the Federal Circuit has taken Cardiovalve’s side after Edwards argued certain heart valve patent claims were invalid. In a final written decision, the U.S. Patent Trial and Appeal Board (PTAB) granted Cardiovalve’s non-contingent motion to amend and supplemental motion to amend, canceling original claims in U.S. Patent No. 10,702,385. […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Legal News, Patent Infringement, Replacement Heart Valves, Structural Heart Tagged With: cardiovalve, Edwards Lifesciences

Venus Medtech acquires mitral, tricuspid valve replacement company Cardiovalve

December 8, 2021 By Sean Whooley

Venus Medtech announced that it acquired Cardiovalve and its transcatheter mitral and tricuspid valve treatment technology. Hangzhou, China-based Venus Medtech will acquire 100% equity interest and corresponding equity at a consideration of $300 million, with payments of the consideration coming in installments subject to the completion of certain milestones. According to a news release, Venus […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Featured, Mergers & Acquisitions, Replacement Heart Valves, Structural Heart Tagged With: cardiovalve, Venus Medtech

15 heart devices that could boost their manufacturers’ sales

May 22, 2020 By Nancy Crotti

Before the coronavirus pandemic hit, medtech companies large and small were making notable news with a number of innovative heart devices. Some of these same companies took a big hit to their bottom lines when the danger of spreading COVID-19 and using up precious personal protective equipment convinced hospitals to limit non-urgent procedures. Now hospitals […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Food & Drug Administration (FDA), Hospital Care, Implants, Regulatory/Compliance, Replacement Heart Valves, Stent Grafts, Stents, Structural Heart, Wall Street Beat Tagged With: Abbott, Aris CV, Cardiofocus, cardiovalve, CE Mark, CryoLife, endospan, FDA, Medtronic, Terumo Aortic, V-Wave

Cardiovalve scores FDA wins for its transcatheter tricuspid valve replacement tech

February 20, 2020 By Chris Newmarker

Cardiovalve (Or Yehuda, Israel) said today that U.S. FDA has granted a breakthrough device designation for its transcatheter tricuspid valve replacement system. FDA also approved an early feasibility study of the system for a tricuspid regurgitation (TR) indication. Cardiovalve touted that it is the first privately held company to have the FDA early feasability study […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Replacement Heart Valves Tagged With: cardiovalve

Cardiovalve launches pivotal TMVR trials

September 21, 2018 By Fink Densford

Israel cardiovascular device developer Cardiovalve said yesterday it launched both the Ahead US and Ahead EU multicenter studies of its Cardiovalve transfemoral mitral valve replacement system. The company’s flagship Cardiovalve system is a novel mitral valve designed for either transferal or transeptal use and is intended to replace the mitral valve through a minimally invasive […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Replacement Heart Valves Tagged With: cardiovalve

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy